SCHEMBL9844522

SCHEMBL9844522

O=C(O)CCCCN1CCC(=C2c3ccccc3Sc3ccccc32)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.57
HTT P42858 1/20 0.57
HTR1A P08908 4/20 0.55
DRD3 P35462 3/20 0.55
SETD7 Q8WTS6 2/20 0.55
CHRM2 P08172 1/20 0.55
ADRA2A P08913 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
CYP2D6 P10635 1/20 0.55
CHRM1 P11229 1/20 0.55
DRD1 P21728 1/20 0.55
TBXA2R P21731 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
CYP2C19 P33261 1/20 0.55
ADRA1A P35348 1/20 0.55
OPRM1 P35372 1/20 0.55
SLC6A3 Q01959 1/20 0.55
KCNH2 Q12809 1/20 0.55
DRD2 P14416 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9844283 0.96 CYP3A4 (0.58) CYP3A4HTTHTR1ADRD3SETD7
Hydrochloric Acid SCHEMBL9844493 0.95 CYP3A4 (0.57) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9844502 0.91 CYP3A4 (0.61) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9844279 0.86 FNTA (0.54) CYP3A4HTTHTR1ADRD3SETD7
Hydrochloric Acid SCHEMBL9844374 0.85 FNTA (0.53) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9844251 0.85 FNTA (0.53) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9844244 0.85 FNTA (0.53) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9844384 0.85 FNTA (0.53) CYP3A4HTTHTR1ADRD3SETD7
SCHEMBL9718809 0.85 SETD7 (0.54) HTR1ADRD3SETD7CHRM2ADRA2A
Hydrochloric Acid SCHEMBL9844268 0.84 FNTA (0.52) CYP3A4HTTHTR1ADRD3SETD7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0451772-A1 Piperidine compounds, method for preparation thereof, and a pharamceutical composition comprising the same HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1991-10-16 EP disclosed